Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

Litigation Details for Network-1 Technologies, Inc. v. Google, L.L.C. (S.D.N.Y. 2014)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Network-1 Technologies, Inc. v. Google, L.L.C. (S.D.N.Y. 2014)

Docket   Start Trial Date Filed 2014-04-04
Court District Court, S.D. New York Date Terminated
Cause 35:271 Patent Infringement Assigned To Paul G. Gardephe
Jury Demand Both Referred To Michael H. Dolinger
Patents 10,046,058
Attorneys Adam S Hoffman; Amy Elizabeth Hayden; Andrew D Gish; Andrew Trask; Brian D. Ledahl; Bruce R. Genderson; Charles Robert Macedo; Christopher Alan Suarez; Daniel P. Shanahan; Douglas R. Nemec; Eli S Schlam; Ian Chen; James J Elacqua; Jessica Bodger Rydstrom; Kevin Hardy; Marc A. Fenster; Marti Alan Johnson; Paul A Kroeger; Samuel Bryant Davidoff
Firms Amster, Rothstein & Ebenstein LLC; Irell & Manella-Los Angeles; Russ August & Kabat; Skadden, Arps, Slate, Meagher & Flom, LLP(CA); Williams & Connolly LLP; Williams & Connolly LLP (DC)
Link to Docket External link to docket
Biologic Drugs cited in Network-1 Technologies, Inc. v. Google, L.L.C.
The biologic drug covered by the patent cited in this case is   Start Trial .

Details for Network-1 Technologies, Inc. v. Google, L.L.C. (S.D.N.Y. 2014)

Date Filed Document No. Description Snippet Link To Document
2015-04-27 68 Brief vectors of known works in a database. Id. at 10:46-58. If the system successfully identifies the work…Use Of Forms Of "Associating" In Patents And Patent Applications…the specification of the patents-in-suit. Network-1 tries to avoid the patents' shortcomings by offering…possible." 1 U.S. Patent Nos. 8,010,988 ("the '988 Patent") (Exh. 1); 8,205,237…quot;the '237 Patent") (Exh. 2); 8,640,179 ("the '179 Patent") (Exh. 3); External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.